AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Bone Biologics Corp Director's Dealing 2017

Apr 21, 2017

35440_dirs_2017-04-21_cbc364b4-b2dc-4096-ad4b-61892892de0e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bone Biologics Corp (BBLG)
CIK: 0001419554
Period of Report: 2016-05-27

Reporting Person: Frelick Jeff (Chief Operating Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-27	Employee Stock Option (Right to Buy)	$2.05	A	269145	Acquired	2026-05-26	Common Stock (269145)	Direct

Footnotes

F1: On May 27, 2016, the Reporting Person was granted 269,145 stock options, 1/3 of the shares subject to the option vest on each anniversary of the Vesting Commencement Date, subject to the option holder's Continuous Service (as defined in the Plan) on each vesting date, provided the Reporting Person is still providing services to the Issuer on the respective date.